NBD AI Bulletin，Hualan Biological Engineering, Inc. (SZ 002007, closing price: 41.18 yuan) announced on the evening of May 31 that its shareholder Yongxin Shengkang reduced its holding in the company by 27,558,000 shares between May 21, 2020 and May 29, 2020, at prices between 38 yuan per share to 39.07 yuan per share. After the sale, shareholder Yongxin Shengkang holds about 13.5 million shares, accounting for 0.74% of the company's total share capital.

According to the 2019 annual report, Hualan Biological Engineering, Inc.'s main businesses are blood products, vaccine products, and others, accounting for 71.46%, 28.19%, and 0.35% of revenue, respectively.

Hualan Biological Engineering, Inc.'s chairman and general manager is An Kang, male, 71 years old, Chinese national, graduated from Henan Normal University's Department of Biology, undergraduate degree, senior engineer in medical biology.

(By Li Menglin)

Disclaimer: This article is for informational purposes only and does Not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.